Lv75
4990 积分 2024-02-04 加入
Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial
8天前
已完结
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer
9天前
已完结
CDK4/6 inhibitors in HER2-positive breast cancer
9天前
已完结
Tumor Intrinsic Subtypes and Gene Expression Signatures in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Pooled Analysis of CALGB 40601, NeoALTTO, and NSABP B-41 Trials
10天前
已完结
Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+ advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial
11天前
已关闭
omission of chemotherapy in the treatment of HER2-positive and hormone-receptor positive metastatic breast cancer – interim results from the randomized phase 3 DETECT V trial
11天前
已关闭
CDK4/6 Inhibitors in HER2-positive Metastatic Breast Cancer
15天前
已关闭
American Society of Breast Surgeons and Society of Breast Imaging 2025 Guidelines for the Management of Benign Breast Fibroepithelial Lesions
15天前
已完结
乳腺叶状肿瘤诊疗临床实践指南
15天前
已完结
皖公网安备34019202002308
